Agios Pharmaceuticals
AGIO
#3539
Rank
NZ$5.24 B
Marketcap
$91.93
Share price
-2.92%
Change (1 day)
146.67%
Change (1 year)

Earnings for Agios Pharmaceuticals (AGIO)

Earnings in 2024 (TTM): -NZ$0.65 Billion

According to Agios Pharmaceuticals 's latest financial reports the company's current earnings are NZ$29.4 Million. In 2023 the company made an earning of -NZ$0.67 Billion a decrease over its 2022 earnings that were of -NZ$0.67 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Agios Pharmaceuticals from 2012 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -NZ$0.65 Billion-3.61%
2023 -NZ$0.67 Billion0.63%
2022 -NZ$0.67 Billion2.81%
2021 -NZ$0.65 Billion10.58%
2020 -NZ$0.59 Billion-18.41%
2019 -NZ$0.72 Billion15.72%
2018 -NZ$0.62 Billion12.99%
2017 -NZ$0.55 Billion59.61%
2016 -NZ$0.35 Billion69.32%
2015 -NZ$0.21 Billion119.28%
2014 -NZ$92.54 Million39.22%
2013 -NZ$66.47 Million69.1%
2012 -NZ$39.31 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-NZ$0.3 Billion-55.79%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$1.02 B-252.67%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$2.08 Billion 208.44%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.66 B-199.62%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$7.12 B-1,161.44%๐Ÿ‡ฌ๐Ÿ‡ง UK
NZ$17.35 B-2,683.18%๐Ÿ‡บ๐Ÿ‡ธ USA